#62 COVID-19 Part-1 Clinician Updates CE 2.0 Total | 1.5 of which are Pharm With the urgent and changing landscape off the COVID-19 Pandemic several urgent needs arise for healthcare providers in the area of patient management. While this CE is NOT meant to re-hash the “known” factors such as social isolation, quarantine, hand washing …
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases CE 1.5 Total | 0.5 of which are Pharm The chronically ill patient is difficult to manage considering their primary concerns regardless of cause. And while they often have infectious, hormonal, GI, toxic or many other underlying conditions to manage it is often the “transitory symptoms” that …
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases Read More »
#35 PHARM Part-13 Migraine Assessment and Treatment CE 2.0 Total | 1.5 of which are Pharm Migraine Myths Migraine is neither an “extreme headache” nor a psychosomatic condition, as many patients and some healthcare providers continue to believe. One of the most pervasive misconceptions is that migraine is a vascular disease. Current and emerging evidence …
#35 PHARM Part-13 Migraine Assessment and Treatment Read More »
#36 PCOS CE 1.5 Total | 1.0 of which are Pharm PCOS – Assessment and Treatment Considerations Dr. Anderson discusses the PCOS, the history, and latest developments, as well as clinical observations.
